Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival.
about
Interleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseThe Newly Identified T Helper 22 Cells Lodge in LeukemiaTh22 cells in allergic diseaseT Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An OverviewTh22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.Th22 cell accumulation is associated with colorectal cancer developmentInterleukin-22: immunobiology and pathology.The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pyloriIncreased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis.Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma.Th22 cells are associated with hepatocellular carcinoma development and progression.IL-22 in tissue-protective therapy.Therapeutic opportunities of the IL-22-IL-22R1 system.The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer.Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies.Interaction between gastric cancer stem cells and the tumor microenvironment.Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.Biological and pathological activities of interleukin-22.Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma.IL-17 and IL-22 in immunity: Driving protection and pathology.Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases.Alterations in Th17 and the Respective Cytokine Levels in Helicobacter pylori-Induced Stomach Diseases.Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytesElevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.IL-22 promotes the progression of breast cancer through regulating HOXB-AS5.Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth.A catch-22: Interleukin-22 and cancer.Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses.Targeting interleukin-22 for cancer therapy.Quantitative and Qualitative Analysis of Tumor-Associated CD4⁺ T Cells.High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.Accumulation of T-helper 22 cells, interleukin-22 and myeloid-derived suppressor cells promotes gastric cancer progression in elderly patients.The Interleukin-20 Cytokines in Intestinal Diseases.Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women
P2860
Q26770224-1099769B-30E2-43A0-81BE-C973A599897EQ26799454-70E14217-2927-4424-AD75-37B317149070Q27023029-C007775B-0295-4662-890B-BF0B48F67103Q28081582-53E7427A-97AC-4FCB-86AA-618FE2CF0B5CQ34510880-63067715-8BA8-4DC3-90FC-DB7A188E7CD4Q35375460-A15C597C-D1DD-4743-A2BF-600D91E829B3Q35530956-80C6F04C-BCD5-44E7-8998-BE114FB2A10CQ35810901-4995DDDB-5BFE-4316-BB22-F85219435E06Q35920946-D143DCE5-BBFD-4581-BD5D-00F61F61579AQ36531638-B0C8BFB3-AF2C-4B46-8240-DCFDD679A576Q37026218-94E47F8C-695C-41B4-9FD8-BF678C980DC0Q37636667-B51EF5A2-28B2-4CC3-99D9-AD416341A2B8Q37725429-025DC397-2152-467D-B2B4-0E7C6E5828C9Q38093227-7F360566-3660-4B25-9509-C95D2DBADF89Q38174792-8E8F73FE-1C34-4224-993A-64E14AD97323Q38181085-8236562E-ED68-435D-86DB-89292ACB42A5Q38196935-42C0412A-B057-469A-B28B-04FB6486285DQ38197931-14E96AB4-3AED-48C7-9F94-96C38939A83DQ38602944-15D580A8-516E-4934-869D-689C18A02F6CQ38753752-269F211C-7624-47A4-9A15-8B781D12F322Q38855371-8E6D1CA7-D63A-4F12-BD8F-96D57B34FC6EQ39102545-51AFB61F-F942-495A-A949-988A73F13A21Q39179415-63EFE7E3-0537-48CC-94FA-8E32C52F8FD4Q39337489-194325CE-CB05-4735-A2F7-872BA02ABF53Q40404670-8D263331-FE80-4851-9160-F9E1B2859268Q41290370-BAA8D593-CFC3-419F-8619-1A78BD120BF6Q41494871-7382CA72-A8B2-44AF-A069-6160F168C30EQ42266144-A124411B-D80C-4DFD-9BDC-B40E3FA0372DQ43760187-D07821FA-4084-49F9-ACF5-BFF025444305Q47159175-1068F948-0885-4601-864C-70044E2D7DF5Q47372478-F30C5722-78B8-474D-B4F4-EDE97FA1CE55Q47390109-8CF83753-1DBA-4032-ADDE-55EF94CF916EQ48231667-279736A9-2A74-48BD-B764-A3C7E0844401Q48306408-AAA4B83C-5864-495A-8A2A-DDEA83BC1ADEQ52721732-815B06B4-333D-4B78-BA46-E022DAADF2DBQ54518729-AE1A0CF2-A96E-4E36-9D8A-C9E12DF4045AQ54744700-CD270678-DD30-4575-81D3-3F1A6E941A61Q55160049-04A92F1D-388D-4369-AF44-0F8B050D88C2Q55399321-4397D09F-E52E-4E21-99D6-89FDD465D0D2Q58763040-4C484195-6E0C-4B29-BA50-B6212818A675
P2860
Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increased intratumoral IL-22-producing CD4
@nl
Increased intratumoral IL-22-p ...... predict poor patient survival.
@en
type
label
Increased intratumoral IL-22-producing CD4
@nl
Increased intratumoral IL-22-p ...... predict poor patient survival.
@en
prefLabel
Increased intratumoral IL-22-producing CD4
@nl
Increased intratumoral IL-22-p ...... predict poor patient survival.
@en
P2093
P2860
P1476
Increased intratumoral IL-22-p ...... predict poor patient survival.
@en
P2093
Jin-Yu Zhang
Liu-Sheng Peng
Quan-Ming Zou
Weisan Chen
Xiao-Fei Liu
P2860
P2888
P304
P356
10.1007/S00262-012-1241-5
P577
2012-04-13T00:00:00Z